E. Gordon Gee President at West Virginia University | Official website
E. Gordon Gee President at West Virginia University | Official website
A West Virginia University physician and researcher has been honored with a prestigious recognition in the fields of health and medicine. Dr. Sally Hodder, who serves as the director of the West Virginia Clinical and Translational Science Institute, associate vice president for clinical and translational science at WVU, and Chancellor’s Preeminent Scholar Chair, has been elected to the National Academy of Medicine (NAM). This accolade is in acknowledgment of her contributions as an infectious diseases physician and researcher.
Dr. Hodder is the first individual from WVU to be selected for this honor, joining 100 new members globally announced at the NAM Annual Meeting on October 21. The election acknowledges those who have shown exceptional professional achievement and contributed significantly to medical sciences, healthcare, and public health advancement.
“Through her extensive, statewide networks and coalitions, Dr. Sally Hodder is transforming health care in West Virginia and beyond by engaging rural communities in novel clinical trials and translational research,” stated Dr. Clay Marsh, chancellor and executive dean for WVU Health Sciences.
He further noted that “Dr. Hodder’s work in rural American communities is helping us understand and address the lack of representation for underserved and underrepresented people in health and medical research studies.” Her efforts aim to enhance treatment protocols for major health issues such as HIV, addiction, long COVID-19, lung and heart health, among other infectious diseases.
The National Academy of Medicine was established as the Institute of Medicine in 1970 by the National Academy of Sciences. It addresses critical issues related to health, science, medicine, policy-making positive impacts across various sectors.
NAM collaborates with the National Academy of Sciences and National Academy of Engineering to provide independent analysis and advice on complex problems affecting public policy decisions.
In its announcement about Dr. Hodder's election, NAM emphasized her leadership role in designing clinical trials focused on underserved rural populations along with her expertise in HIV treatment/prevention research areas including addiction mentorship engagement within community settings.
Since joining WVU back in 2014 leading NIH-funded initiatives like West Virginia Clinical & Translational Science Institute (WVCTSI), she has played an integral part supporting university missions serving state residents while developing crucial connections between researchers clinicians professionals throughout regionally impacted communities across West Virginia.
WVCTSI receives funding through IDeA Clinical Translational Research award provided by National Institute General Medical Sciences (U54GM104942) aimed building infrastructure capacity addressing disparities within state-level healthcare systems
Alerts Sign-up